Menu
Menu

We Can Help You Talk to Your Current Doctor

We understand how conversations with your doctor about treatment options for your severe COPD/Emphysema can be challenging, so we’re here to help! We can share information about the Zephyr Valve treatment with your current doctor so they can be prepared to have a conversation with you about whether you may qualify for treatment.

More than 25,000 patients have been treated with Zephyr Valves, but many doctors are still learning about this newer treatment category.

Talk To My Doctor – OI-5A-v3
Treatment-Options-Severe-Emphysema-COPD

Take a moment to complete this form, and we will send your doctor information about this minimally invasive treatment to help determine whether this treatment option may be right for you.

Your current doctor will receive information on the following:

  • Types of patients who are likely to benefit and be eligible for the procedure
  • The tests that will be done and the diagnoses required during the treatment evaluation
  • Benefits for your health and potential quality of life improvements
  • The potential risks and complications of the procedure

For U.S. Only

US-EN-1030-v1

Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. Complications of treatment can include but are not limited to pneumothorax (tear in the lung), worsening of COPD symptoms, hemoptysis, pneumonia, and, in rare cases, death. The Zephyr Valve is contraindicated in patients who have not quit smoking or are allergic to Nitinol (nickel-titanium). Please talk with your physician about other contraindications, warnings, precautions, and adverse events. Only a trained physician can decide whether a particular patient is an appropriate candidate for treatment with the Zephyr Valve.

© 2021-Present Pulmonx Corporation or its affiliates.  All rights reserved. All trademarks are property of their respective owners.

Site Designed by The Deciding Factor, Inc.

Talk To My Doctor – OI-5A-v3

Follow Us

Follow Us

Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. Complications of treatment can include but are not limited to pneumothorax (tear in the lung), worsening of COPD symptoms, hemoptysis, pneumonia, and, in rare cases, death. The Zephyr Valve is contraindicated in patients who have not quit smoking or are allergic to Nitinol (nickel-titanium). Please talk with your physician about other contraindications, warnings, precautions, and adverse events. Only a trained physician can decide whether a particular patient is an appropriate candidate for treatment with the Zephyr Valve.

© 2021-Present Pulmonx Corporation or its affiliates.  All rights reserved. All trademarks are property of their respective owners.

Site Designed by The Deciding Factor, Inc.

Talk To My Doctor – OI-5A-v3